Norton Rose-Led FibroBiologics Pulls Off Direct Listing
Shares of drug developer FibroBiologics Inc. debuted in trading Wednesday after the chronic-disease focused company completed a direct listing, an alternative to a traditional initial public offering, represented by Norton Rose...To view the full article, register now.
Already a subscriber? Click here to view full article